Management ChangeJun 3, 2026, 07:01 AM
Cocrystal Pharma Appoints James Sapirstein as CEO
AI Summary
Cocrystal Pharma, Inc. announced the appointment of James Sapirstein as its new Chief Executive Officer, effective immediately. Mr. Sapirstein, a biopharma industry leader with extensive antiviral development experience, will also be appointed to the Board of Directors. He replaces former Co-Chief Executive Officers Sam Lee and Jim Martin, who will transition to President and Chief Scientific Officer, and Chief Financial Officer, respectively. The company expects Mr. Sapirstein's experience to accelerate its clinical programs.
Key Highlights
- Cocrystal Pharma appointed James Sapirstein as Chief Executive Officer, effective immediately.
- Mr. Sapirstein is also planned to be appointed as a member of the Board of Directors.
- He replaces Sam Lee and Jim Martin, who served as Co-Chief Executive Officers.
- Sam Lee will transition to President and Chief Scientific Officer.
- Jim Martin will continue as Chief Financial Officer.
- Mr. Sapirstein has extensive biopharma industry leadership and development experience, including 23 product launches.
Price Impact
More from COCP